Moderna Inc (MRNA)
Fixed asset turnover
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 3,229,000 | 5,076,000 | 5,052,000 | 5,155,000 | 6,826,000 | 9,097,000 | 10,486,000 | 14,708,000 | 18,810,000 | 20,675,000 | 22,284,000 | 21,933,000 | 17,736,000 | 11,016,375 | 6,199,591 | 2,013,033 | 274,490 | 55,668 | 56,790 | 38,378 |
Property, plant and equipment | US$ in thousands | — | — | — | — | — | 2,717,000 | 2,410,000 | — | 2,139,000 | 2,132,000 | 1,446,000 | 1,473,000 | 1,383,000 | 960,000 | 898,000 | 461,000 | 387,090 | 368,593 | 321,985 | 302,599 |
Fixed asset turnover | — | — | — | — | — | 3.35 | 4.35 | — | 8.79 | 9.70 | 15.41 | 14.89 | 12.82 | 11.48 | 6.90 | 4.37 | 0.71 | 0.15 | 0.18 | 0.13 |
December 31, 2024 calculation
Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $3,229,000K ÷ $—K
= —
Fixed asset turnover is a financial ratio that measures a company's efficiency in generating sales from its fixed assets. A higher fixed asset turnover indicates that the company is making more efficient use of its fixed assets to generate revenue.
Analyzing Moderna Inc's fixed asset turnover over the historical period, we observe a significant increase in the ratio, starting from a low of 0.13 in March 2020 to a peak of 15.41 in June 2022. This substantial improvement suggests that Moderna has been able to increase its sales relative to its investment in fixed assets.
However, the ratio experienced a decline in the subsequent periods, dropping to 4.35 in June 2023 and further to 3.35 in September 2023. This decline could indicate that Moderna's sales growth has slowed down relative to its fixed asset base during these periods.
The ratio showed some fluctuation in the later periods, settling at 8.79 in December 2022. The absence of data for the subsequent periods makes it challenging to provide a more current analysis of Moderna's fixed asset turnover.
Overall, the trend in Moderna's fixed asset turnover showcases periods of significant improvement in asset utilization efficiency, followed by some fluctuations and declines. Analyzing this ratio alongside other financial metrics can provide a more comprehensive understanding of the company's operational performance and future prospects.
Peer comparison
Dec 31, 2024